Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
PagSeguro Digital
PAGS
$2.69B
| $1.27M | ﹤0.01% |
134,830
-5,136,287
| -97% | -$52.1M |
|
3777
Village Super Market
VLGEA
$651M
| $1.27M | ﹤0.01% |
55,717
+15,201
| +38% | +$330K |
|
3778
Kymera Therapeutics
KYMR
$8.51B
| $1.27M | ﹤0.01% |
+55,201
| New | +$1.58M |
|
3779
Usana Health Sciences
USNA
$408M
| $1.27M | ﹤0.01% |
20,130
+11,928
| +145% | +$760K |
|
3780
Sportradar
SRAD
$4.3B
| $1.27M | ﹤0.01% |
98,312
-244,212
| -71% | -$2.94M |
|
|
EPIX
3781
DELISTED
ESSA Pharma
EPIX
| $1.27M | ﹤0.01% |
469,002
+49,935
| +12% | +$146K |
|
3782
PUT
Everest Group
EG
$14.5B
| $1.26M | ﹤0.01% |
+3,700
| New | +$1.34M |
|
3783
Vroom Inc
VRM
$39M
| $1.26M | ﹤0.01% |
10,976
+8,407
| +327% | +$641K |
|
|
VAPO
3784
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.26M | ﹤0.01% |
354,355
-14,395
| -4% | -$66K |
|
3785
CALL
SoFi Technologies
SOFI
$21B
| $1.26M | ﹤0.01% |
151,200
+8,000
| +6% | +$52.2K |
|
|
MREO
3786
Mereo BioPharma
MREO
$54.7M
| $1.26M | ﹤0.01% |
955,071
-1,550,559
| -62% | -$1.8M |
|
|
MDRX
3787
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.26M | ﹤0.01% |
+100,000
| New | +$1.21M |
|
|
VISN
3788
Vistance Networks Inc
VISN
$2.65B
| $1.26M | ﹤0.01% |
223,088
-1,749,680
| -89% | -$8.36M |
|
|
GATO
3789
DELISTED
Gatos Silver, Inc.
GATO
| $1.26M | ﹤0.01% |
332,268
+49,548
| +18% | +$267K |
|
|
CCF
3790
DELISTED
Chase Corporation
CCF
| $1.26M | ﹤0.01% |
+10,356
| New | +$1.19M |
|
|
CALB
3791
DELISTED
California BanCorp Common Stock
CALB
| $1.26M | ﹤0.01% |
83,690
-20,240
| -19% | -$315K |
|
3792
Select Water Solutions
WTTR
$2.3B
| $1.25M | ﹤0.01% |
154,617
-208,406
| -57% | -$1.58M |
|
3793
CALL
Manulife Financial
MFC
$73.9B
| $1.25M | ﹤0.01% |
50,000
-250,000
| -83% | -$4.77M |
|
3794
Nuveen Multi-Asset Income Fund
NMAI
$468M
| $1.25M | ﹤0.01% |
+107,291
| New | +$1.24M |
|
3795
PUT
Cloudflare
NET
$99B
| $1.25M | ﹤0.01% |
19,100
+14,300
| +298% | +$853K |
|
3796
CALL
Incyte
INCY
$24.2B
| $1.25M | ﹤0.01% |
+20,000
| New | +$1.34M |
|
3797
iShares MSCI Peru and Global Exposure ETF
EPU
$537M
| $1.24M | ﹤0.01% |
40,601
-30,115
| -43% | -$924K |
|
3798
On Holding
ONON
$12.1B
| $1.24M | ﹤0.01% |
37,683
-954,775
| -96% | -$29M |
|
|
DCH
3799
PUT
Dauch Corp
DCH
$1.34B
| $1.24M | ﹤0.01% |
150,200
-300
| -0.2% | -$2.22K |
|
|
SPRB
3800
Spruce Biosciences
SPRB
$118M
| $1.24M | ﹤0.01% |
7,702
-416
| -5% | -$69.6K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.